Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis

被引:58
作者
Liu, T.
Laurell, C.
Selivanova, G.
Lundeberg, J.
Nilsson, P.
Wiman, K. G. [1 ]
机构
[1] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, SE-17176 Stockholm, Sweden
[2] Royal Inst Technol, Dept Gene Technol, Sch Biotechnol, Stockholm, Sweden
[3] Karolinska Inst, Microbiol & Tumor Biol Ctr, Stockholm, Sweden
关键词
p53; hypoxia; apoptosis; microarray analysis; p53 target genes;
D O I
10.1038/sj.cdd.4402022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 triggers apoptosis in response to cellular stress. We analyzed p53-dependent gene and protein expression in response to hypoxia using wild-type p53-carrying or p53 null HCT116 colon carcinoma cells. Hypoxia induced p53 protein levels and p53-dependent apoptosis in these cells. cDNA microarray analysis revealed that only a limited number of genes were regulated by p53 upon hypoxia. Most classical p53 target genes were not upregulated. However, we found that Fas/CD95 was significantly induced in response to hypoxia in a p53-dependent manner, along with several novel p53 target genes including ANXA1, DDIT3/ GADD153 (CHOP), SEL1L and SMURF1. Disruption of Fas/CD95 signalling using anti-Fas-blocking antibody or a caspase 8 inhibitor abrogated p53-induced apoptosis in response to hypoxia. We conclude that hypoxia triggers a p53-dependent gene expression pattern distinct from that induced by other stress agents and that Fas/CD95 is a critical regulator of p53-dependent apoptosis upon hypoxia.
引用
收藏
页码:411 / 421
页数:11
相关论文
共 40 条
[21]   Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts [J].
Lindström, MS ;
Wiman, KG .
ONCOGENE, 2003, 22 (32) :4993-5005
[22]  
LUETHY JD, 1992, CANCER RES, V52, P5
[23]   Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bc12 and perturbing the cellular redox state [J].
McCullough, KD ;
Martindale, JL ;
Klotz, LO ;
Aw, TY ;
Holbrook, NJ .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (04) :1249-1259
[24]   Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity [J].
McPherson, JP ;
Tamblyn, L ;
Elia, A ;
Migon, E ;
Shehabeldin, A ;
Matysiak-Zablocki, E ;
Lemmers, B ;
Salmena, L ;
Hakem, A ;
Fish, J ;
Kassam, F ;
Squire, J ;
Bruneau, BG ;
Hande, MP ;
Hakem, R .
EMBO JOURNAL, 2004, 23 (18) :3677-3688
[25]   Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias [J].
Mitsiades, N ;
Mitsiades, CS ;
Poulaki, V ;
Anderson, KC ;
Treon, SP .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (08) :1521-1530
[26]   From mono- to oligo-Smads:: The heart of the matter in TGF-β signal transduction [J].
Moustakas, A ;
Heldin, CH .
GENES & DEVELOPMENT, 2002, 16 (15) :1867-1871
[27]   p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs [J].
Müller, M ;
Wilder, S ;
Bannasch, D ;
Israeli, D ;
Lehlbach, K ;
Li-Weber, M ;
Friedman, SL ;
Galle, PR ;
Stremmel, W ;
Oren, M ;
Krammer, PH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2033-2045
[28]   hTERT antagonizes p53-induced apoptosis independently of telomerase activity [J].
Rahman, R ;
Latonen, L ;
Wiman, KG .
ONCOGENE, 2005, 24 (08) :1320-1327
[29]   CDNA SEQUENCE AND CHROMOSOMAL LOCALIZATION OF A NOVEL HUMAN PROTEIN, RBQ-1 (RBBP6), THAT BINDS TO THE RETINOBLASTOMA GENE-PRODUCT [J].
SAKAI, Y ;
SAIJO, M ;
COELHO, K ;
KISHINO, T ;
NIIKAWA, N ;
TAYA, Y .
GENOMICS, 1995, 30 (01) :98-101
[30]   Modulation of cell death pathways to apoptosis and necrosis of H2O2-treated rat thymocytes by lipocortin I [J].
Sakamoto, T ;
Repasky, WT ;
Uchida, K ;
Hirata, A ;
Hirata, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (03) :643-647